Frederic Becq
9Patents
2h-index
25Co-inventors
47Inventor score
Filing activity: Mar 2, 1999 → Dec 4, 2015
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6630482B1 | CFTR channel activator compounds and pharmaceutical compositions containing same | Chemistry; Metallurgy | 10 | Expired |
| US7973054B2 | Use of glucosidase inhibitors for therapy of mucovisidosis | Human Necessities | 4 | Expired |
| US8492420B2 | Use of purine derivatives for the production of medicaments for the treatment of mucoviscidosis and diseases related to protein addressing errors in cells | Human Necessities | 1 | Active |
| US8252958B2 | Use of guanabenz and its derivatives for making drugs for treating cystic fibrosis and diseases related to a protein addressing deficiency in the cells | Human Necessities | 0 | Active |
| US7897610B2 | Use of benzo[c]quinolizinium derivatives for the treatment of diseases that are linked to smooth muscle cell constriction | Chemistry; Metallurgy | 0 | Expired |
| US7605153B2 | Use of paullone derivatives for the production of medicaments for the treatment of mucoviscidosis and diseases related to protein addressing errors in cells | Human Necessities | 0 | Active |
| US10414768B2 | Compounds for treating cystic fibrosis | Chemistry; Metallurgy | 0 | Active |
| US7772198B2 | CFTR channel modulators | Chemistry; Metallurgy | 0 | Active |
| US8242136B2 | Use of glucosidase inhibitors for therapy of mucovisidosis | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.